BIONTECH SE (BNTX): Price and Financial Metrics
BIONTECH SE (BNTX)
Today's Latest Price: $104.96 USD
Updated Nov 25 4:00pm
Add BNTX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
BNTX Stock Summary
- BNTX's went public 1.13 years ago, making it older than only 0.83% of listed US stocks we're tracking.
- With a price/sales ratio of 200.18, BioNTech SE has a higher such ratio than 98.13% of stocks in our set.
- In terms of twelve month growth in earnings before interest and taxes, BioNTech SE is reporting a growth rate of 292.66%; that's higher than 95.1% of US stocks.
- Stocks that are quantitatively similar to BNTX, based on their financial statements, market capitalization, and price volatility, are BGNE, MRNA, INCY, ARGX, and DNLI.
- Visit BNTX's SEC page to see the company's official filings. To visit the company's web site, go to www.biontech.de.
BNTX Stock Price Chart Interactive Chart >
BNTX Price/Volume Stats
| Current price | $104.96 | 52-week high | $115.00 |
| Prev. close | $101.87 | 52-week low | $20.49 |
| Day low | $99.10 | Volume | 3,007,400 |
| Day high | $106.06 | Avg. volume | 2,153,023 |
| 50-day MA | $86.45 | Dividend yield | N/A |
| 200-day MA | $63.95 | Market Cap | 23.75B |
BIONTECH SE (BNTX) Company Bio
BioNTech SE focuses on the development of molecular immune therapies and biomarker-based diagnostic approaches. The firm develops and manufactures biomarker-based in vitro diagnostic devices (IVDD) and commercializes products. It offers drug discovery services for therapeutic areas including infectious diseases, allergies and autoimmune disorders.
Loading social stream, please wait...